We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Timber Pharmaceuticals Inc | AMEX:TMBR | AMEX | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.3426 | 0 | 01:00:00 |
The Virtual Summer Summit will take place entirely online and feature over 500 registered executives and qualified investors viewing virtual company presentations and attending one-on-one meetings.
To attend the virtual presentation, please go to the following link on Tuesday, June 9th at 2:10pm ET: https://www.webcaster4.com/Webcast/Page/2038/35017
For more information, please visit: www.microcapconf.com.
About Timber Pharmaceuticals, Inc.
Timber Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. The company's investigational therapies have proven mechanisms-of-action backed by decades of clinical experience and well-established CMC (chemistry, manufacturing, and control) and safety profiles. Timber is initially focused on developing non-systemic treatments for rare dermatologic diseases including congenital ichthyosis (CI), facial angiofibromas in tuberous sclerosis complex (TSC), and localized scleroderma. For more information, visit www.timberpharma.com.
For more information, contact:
Timber Pharmaceuticals, Inc. John Koconis Chief Executive Officerjkoconis@timberpharma.com
Investor Relations:Stephanie PrincePCG Advisory(646) 762-4518sprince@pcgadvisory.com
Media Relations: Adam DaleyBerry & Company Public Relations 212-253-8881adaley@berrypr.com
1 Year Timber Pharmaceuticals Chart |
1 Month Timber Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions